Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

481-30-1

Epitestosterone-17

481-30-1
07/07/9002

Trypsine pancreatic boeuf

07/07/9002
144701-48-4

Telmisartan

144701-48-4
23313-80-6

Tetracyclin 4-epi HCl

23313-80-6
501-94-0

Tyrosol

501-94-0
76-25-5

Triamcinolone Acetonide

76-25-5
562-74-3

Terpinen-4-ol

562-74-3
76-75-5

Thiopental

76-75-5
64461-82-1

Tizanidin HCl

64461-82-1
13710-19-5

Tolfenamic acid

13710-19-5
521-78-8

Trimipramine Maleate Salt

521-78-8
280755-12-6

Tulathromycin

280755-12-6
143-24-8

Tetraglyme

143-24-8
112-49-2

Triglyme

112-49-2
32986-56-4

Tobramycin

32986-56-4
15318-45-3

Thiamphenicol

15318-45-3
217500-96-4

Tulathromycin A

217500-96-4
63409-12-1

Tylvalosin

63409-12-1
171596-29-5

Tadalafil

171596-29-5
55297-96-6

Tiamulin Fumarate

55297-96-6